FDA Legislative Developments: What to Expect in Potential Year-End Packages
Tuesday, October 28, 2025
11:00 a.m. - 12:15 p.m.
Panelists will discuss various legislative proposals that Congress is considering in the FDA regulatory space, including legislation on qualitative and quantitative (Q1/Q2) sameness, interchangeability, and clinical studies.
Kurt Karst, JD
Director, Hyman Phelps McNamara
Brian McCormick, JD
Vice President, Chief Regulatory Counsel & Head, Global Regulatory Policy, Teva Pharmaceuticals
Kim Trzeciak
Senior Vice President, Capitol Hill Consulting Group
Moderator: Eva Temkin, JD
Partner, Arnold & Porter
